Skip to content

Endoscopic Therapy for Laterally Spreading Tumors (LSTs)

Hybrid Versus Conventional Endoscopic Submucosal Dissection for Laterally Spreading Tumors (LSTs): A Retrospective Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06464874
Acronym
LST
Enrollment
890
Registered
2024-06-18
Start date
2020-05-01
Completion date
2023-12-30
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Compare the Efficacy and Safety of Hybrid ESD and ESD in the Treatment of Colorectal LST

Keywords

Colorectal adenoma;Laterally spreading tumors, Endoscopic submucosal dissection, Hybrid endoscopic submucosal dissection

Brief summary

This study will retrospectively include LST patients who were admitted to 6 medical centers (The Second Affiliated Hospital, College of Medicine, Zhejiang University; The Affiliated Jinhua Hospital, Zhejiang University School of Medicine; First Affiliated Hospital of Huzhou University; The Second Hospital of Jiaxing; Jinhua People's Hospital; Lanxi People's Hospital) from 2020.05.01 to 2023.04.30 with the purpose of comparing the efficacy and safety of hybrid ESD and ESD in the treatment of colorectal LST. The complete resection rate, operation time, operation cost, intraoperative and postoperative complications of hybrid ESD and ESD LST will be compared. To provide strong evidence for the selection of endoscopic treatment strategies for LST.

Interventions

Conventional ESD is the most suitable method for total resection, especially for large lesions. This method can complete the resection of early gastrointestinal cancer and precancerous lesions, while maintaining the integrity of digestive tract anatomy and physiological function.The operation difficulty of this technique is high, the equipment requirements are high, the operation time is long, and the complication rate is closely related to the technical level of the operator.

PROCEDUREHybrid ESD

Hybrid ESD is a better choice, but only can remove the lesion in one piece, but also has a lower technical difficulty than conventional ESD

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years old; * LST lesion diameter \>1cm; * Medical record data integrity

Exclusion criteria

* Pedicle lesions; * Resection of residual lesions after endoscopic treatment; * Advanced endoscopic imaging showed submucosal infiltrating lesions. * The lesions are in patients with inflammatory bowel disease; * Familial polyposis; * Electrolyte abnormalities; * Coagulation dysfunction; * Pregnant or lactating patients; * Taking nonsteroidal anti-inflammatory drugs or anticoagulants; * A history of alcoholism; * Severe organ failure; * Medical records are incomplete

Design outcomes

Primary

MeasureTime frameDescription
complete resection rate2 weeksOne-time complete excision

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026